"It is estimated that by 2030, 30 million GLP-1 [receptor agonist] prescriptions ... The cause is unknown but might be similar to the mechanism of worsened diabetic retinopathy," Warner noted.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

These are likely mechanisms by which GLP-1 may impact neuropsychiatric conditions.” — Ziyad Al-Aly, MD “I think there is clearly (an) added benefit for several conditions. For example ...

numerous diseases are likely underpinned by common fundamental mechanisms—like inflammation, insulin resistance and oxidative stress—that GLP-1 based drugs can positively impact,” Greig says.

Nobody could have predicted the vogue for GLP-1 drugs to promote weight loss ... into their promotional activities or legal action from consumers, sparking lengthy legal proceedings and ...

11 These mechanisms will be important to more fully elucidate to inform whether targeting central or peripheral GLP-1 receptors is necessary and thus whether higher CNS drug concentrations are needed.

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.